Custom Health and Berenson announce plan to trade on the NYSE
Custom Health Inc. and Berenson Acquisition Corp. I (NYSE American: BACA) today announced their definitive Business Combination Agreement that is expected to result in Custom Health becoming a publicly-listed company. The transaction implies a USD $185 million pre-money equity value for Custom Health. Proceeds from the transaction and related financing are expected to be used to fuel organic growth and allow Custom Health to continue to execute on its proven add-on acquisition strategy.
Read more about this transformative partnership: Custom Health Inc. To Go Public Through Business Combination with Berenson Acquisition Corp. I (newsfilecorp.com)